IUG vs. EKF, CREO, NCYT, BELL, POLX, IHC, AVO, MHC, RUA, and SUN
Should you be buying Intelligent Ultrasound Group stock or one of its competitors? The main competitors of Intelligent Ultrasound Group include EKF Diagnostics (EKF), Creo Medical Group (CREO), Novacyt (NCYT), Belluscura (BELL), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), RUA Life Sciences (RUA), and Surgical Innovations Group (SUN). These companies are all part of the "medical devices" industry.
Intelligent Ultrasound Group vs.
Intelligent Ultrasound Group (LON:IUG) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and community ranking.
In the previous week, Intelligent Ultrasound Group and Intelligent Ultrasound Group both had 1 articles in the media. EKF Diagnostics' average media sentiment score of 0.67 beat Intelligent Ultrasound Group's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the news media.
EKF Diagnostics received 327 more outperform votes than Intelligent Ultrasound Group when rated by MarketBeat users.
EKF Diagnostics has a net margin of 9.37% compared to Intelligent Ultrasound Group's net margin of -33.78%. EKF Diagnostics' return on equity of 7.58% beat Intelligent Ultrasound Group's return on equity.
EKF Diagnostics has higher revenue and earnings than Intelligent Ultrasound Group. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.
Intelligent Ultrasound Group has a beta of 0.38, suggesting that its stock price is 62% less volatile than the S&P 500. Comparatively, EKF Diagnostics has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500.
75.5% of Intelligent Ultrasound Group shares are held by institutional investors. Comparatively, 70.3% of EKF Diagnostics shares are held by institutional investors. 12.8% of Intelligent Ultrasound Group shares are held by company insiders. Comparatively, 5.2% of EKF Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
EKF Diagnostics beats Intelligent Ultrasound Group on 10 of the 13 factors compared between the two stocks.
Get Intelligent Ultrasound Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for IUG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Intelligent Ultrasound Group Competitors List
Related Companies and Tools
This page (LON:IUG) was last updated on 1/22/2025 by MarketBeat.com Staff